-
公开(公告)号:US08318802B2
公开(公告)日:2012-11-27
申请号:US12278061
申请日:2007-02-02
申请人: Naglesh R. Palepu
发明人: Naglesh R. Palepu
CPC分类号: A61K9/19 , A61K9/0019 , A61K31/557 , A61K31/5585 , A61K47/183 , A61K47/26
摘要: This invention relates to a stable epoprostenol composition that can be combined with commercially available IV fluids and can be administered in its reconstituted and/or diluted form under ambient conditions of about 15-30° C. for greater than 24 hours. The composition preferably contains (a) epoprostenol or a salt thereof; (b) a alkalinization agent; and (c) a base, such that when reconstituted or in solution, the solution has a pH>11. Methods for making the lyophilized composition are also disclosed.
摘要翻译: 本发明涉及一种稳定的前荚MP素组合物,其可与市售IV液体组合,并且可以在约15-30℃的环境条件下以其重构和/或稀释形式施用大于24小时。 组合物优选含有(a)依前列醇或其盐; (b)碱化剂; 和(c)碱,使得当重构或溶解时,溶液的pH> 11。 还公开了制备冻干组合物的方法。